Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 21, 2008; 14(15): 2349-2357
Published online Apr 21, 2008. doi: 10.3748/wjg.14.2349
Published online Apr 21, 2008. doi: 10.3748/wjg.14.2349
Gene | Normal state | Cirrhotic state | Treated group | Cirrhotic/normal | Treated/cirrhotic |
VEGF-D/FIGF | 5.790E-2 | 1.337E-2 | 2.936E-1 | 0.2309 | 21.950 |
VEGF-C | 1.700E-1 | 1.099E-1 | 2.807E-1 | 0.6467 | 2.5530 |
VEGF-B | 8.275E-2 | 5.057E-2 | 4.079E-1 | 0.6111 | 8.0650 |
VEGF/VEGI | 8.344E-3 | 8.914E-4 | 2.536E-3 | 0.1068 | 2.8450 |
VEGFR | 2.054E+0 | 2.368E+0 | 2.237E+0 | 1.1530 | 0.9448 |
VEGFR2/FLK1 | 1.892E-2 | 1.586E-1 | 1.338E-1 | 8.3800 | 0.8438 |
- Citation: Xu H, Shi BM, Lu XF, Liang F, Jin X, Wu TH, Xu J. Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats. World J Gastroenterol 2008; 14(15): 2349-2357
- URL: https://www.wjgnet.com/1007-9327/full/v14/i15/2349.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2349